Cancer Clinical Trial
Official title:
#4Corners4Health: A Social Media Cancer Prevention Program for Rural Emerging Adults
Young adults aged 18-26 engage in a number of behaviors that increase their risk of developing cancer later in life including sedentary lifestyles, unhealthy eating, nicotine produce us, heavy drinking of alcohol, increased UV exposure, and incomplete uptake of HPV vaccination. A multi-risk factor campaign will be developed to reduce these cancer risk behaviors and delivered to young adults over social media, a popular channel that can reach nearly all young adults. The campaign will be evaluated for effectiveness in a rigorous randomized trial with measures of moderate to vigorous physical activity, healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination uptake.
Status | Not yet recruiting |
Enrollment | 1000 |
Est. completion date | February 28, 2027 |
Est. primary completion date | November 30, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 26 Years |
Eligibility | Inclusion Criteria: - Aged 18-26 years old - Resides in a county coded as RUCC 4-9 in Arizona, Colorado, New Mexico, or Utah - Able to speak and read English - Has regular social media engagement - Accepts screening call from study staff - Consents to participate Exclusion Criteria: - Participated in community engagement activities - Cannot speak and read English - Has low or no social media engagement - Does not accept a screening call from study staff - Does not consent to participate - Does not give permission for engagement data to be extracted from Facebook private group - If biologically female, currently pregnant |
Country | Name | City | State |
---|---|---|---|
United States | University of New Mexico | Albuquerque | New Mexico |
United States | University of Colorado Denver | Aurora | Colorado |
United States | Colorado State University | Fort Collins | Colorado |
United States | University of Utah | Salt Lake City | Utah |
United States | University of Arizona | Tucson | Arizona |
Lead Sponsor | Collaborator |
---|---|
Klein Buendel, Inc. | Colorado State University, National Cancer Institute (NCI), University of Arizona, University of Colorado, Denver, University of New Mexico, University of Utah |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Physical Activity | Participants will self-report minutes per week of moderate to vigorous physical activity. | Baseline | |
Primary | Physical Activity | Participants will self-report minutes per week of moderate to vigorous physical activity. | 3 months | |
Primary | Physical Activity | Participants will self-report minutes per week of moderate to vigorous physical activity. | 12 months | |
Primary | Physical Activity | Participants will self-report minutes per week of moderate to vigorous physical activity. | 24 months | |
Primary | Diet | Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. | Baseline | |
Primary | Diet | Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. | 3 months | |
Primary | Diet | Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. | 12 months | |
Primary | Diet | Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats. | 24 months | |
Primary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). | Baseline | |
Primary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). | 3 months | |
Primary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). | 12 months | |
Primary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all). | 24 months | |
Primary | Alcohol Intake | Participants self-report consumption of number of alcoholic drinks in the past 30 days. | Baseline | |
Primary | Alcohol Intake | Participants self-report consumption of number of alcoholic drinks in the past 30 days. | 3 months | |
Primary | Alcohol Intake | Participants self-report consumption of number of alcoholic drinks in the past 30 days. | 12 months | |
Primary | Alcohol Intake | Participants self-report consumption of number of alcoholic drinks in the past 30 days. | 24 months | |
Primary | Uv Exposure | Participants will self-report number of sunburns. | Baseline | |
Primary | Uv Exposure | Participants will self-report number of sunburns. | 3 months | |
Primary | Uv Exposure | Participants will self-report number of sunburns. | 12 months | |
Primary | Uv Exposure | Participants will self-report number of sunburns. | 24 months | |
Primary | HPV Vaccination | Participants will self-report whether or not they have received one or more doses of the HPV vaccine. | Baseline | |
Primary | HPV Vaccination | Participants will self-report whether or not they have received one or more doses of the HPV vaccine. | 3 months | |
Primary | HPV Vaccination | Participants will self-report whether or not they have received one or more doses of the HPV vaccine. | 12 months | |
Primary | HPV Vaccination | Participants will self-report whether or not they have received one or more doses of the HPV vaccine. | 24 months | |
Secondary | Physical Activity | Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. | Baseline | |
Secondary | Physical Activity | Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. | 3 months | |
Secondary | Physical Activity | Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. | 12 months | |
Secondary | Physical Activity | Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation. | 24 months | |
Secondary | Diet | Participants will self-report frequency of eating meals away from home/fast food. | Baseline | |
Secondary | Diet | Participants will self-report frequency of eating meals away from home/fast food. | 3 months | |
Secondary | Diet | Participants will self-report frequency of eating meals away from home/fast food. | 12 months | |
Secondary | Diet | Participants will self-report frequency of eating meals away from home/fast food. | 24 months | |
Secondary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). | Baseline | |
Secondary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). | 3 months | |
Secondary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). | 12 months | |
Secondary | Nicotine Product Use | Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all). | 24 months | |
Secondary | Nicotine Product Use | Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). | Baseline | |
Secondary | Nicotine Product Use | Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). | 3 months | |
Secondary | Nicotine Product Use | Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). | 12 months | |
Secondary | Nicotine Product Use | Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit). | 24 months | |
Secondary | Alcohol Intake | Participants will self-report number of times binge drinking in the past 30 days. | Baseline | |
Secondary | Alcohol Intake | Participants will self-report number of times binge drinking in the past 30 days. | 3 months | |
Secondary | Alcohol Intake | Participants will self-report number of times binge drinking in the past 30 days. | 12 months | |
Secondary | Alcohol Intake | Participants will self-report number of times binge drinking in the past 30 days. | 24 months | |
Secondary | UV Exposure | Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. | Baseline | |
Secondary | UV Exposure | Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. | 3 months | |
Secondary | UV Exposure | Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. | 12 months | |
Secondary | UV Exposure | Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection. | 24 months | |
Secondary | HPV Vaccination | Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. | Baseline | |
Secondary | HPV Vaccination | Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. | 3 months | |
Secondary | HPV Vaccination | Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. | 12 months | |
Secondary | HPV Vaccination | Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine. | 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|
||
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|